Participatory study on the epidemiology of Haemorrhagic Septicaemia in camels (Camelus dromedarius) in Northern Kenya complemented by bacteriological analysis and molecular identification and differentiation. (360G-Wellcome-081073_Z_06_Z)
The project goal is to develop control recommendations for Haemorrhagic Septicaemia (HS) of camels, a disease which has a serious impact on pastoralist livelihoods. Conventional bacteriological methods have so far failed to identify the causative agent and currently applied treatment strategies are unsuccessful. HS vaccines - based on bovine isolates of P. multocida Carter serotypes B:2 and E:2 (the classical HS agent in cattle) - are used in camels by relief and development organizations in Sudan, Ethiopia, Northern Kenya and Somalia. However, the adequacy and protective effect of these vaccinations has never been assessed. Camel keepers have a profound understanding of the disease which is yet untapped. At the same time new diagnostic tools have become availale for Pasteurella species. The project combines Particpatory Epidemiolgy and aetiological investigations to: Build up an epidemiological database on HS in camels Determine the carrier status of camels for Pasteurella multocida and other Pasteurella species in North East Kenya Investigate outbreaks of HS in camels and to identify Pasteurella multocida and other potential pathogens using bacteriological and molecular tools (Polymerase Chain Reaction, PCR) Develop recommendations on vaccine use and improved treatment protocols for HS in camels Disseminate the study results back to camel owners, veterinary auxiliaries and professionals and relevant organisations involved in provision of animal health services to pastoralist communities Develop an HS-booklet for publication of the findings for field use as well as scientific publications All field (PE and sample collection) and workshop activities, dissemination of results and overall project management will be under VSF-Suisse. Diagnostic work will be carried out in collaboration with VSF-Germany and Analabs Ltd., a private veterinary laboratory. Molecular investigations will be based at the Institute of Microbiology and Epizootics, Veterinary Faculty of the Freie Universität Berlin.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Region | International |
| Award Date | 2006-02-28T00:00:00+00:00 |
| Internal ID | 081073/Z/06/Z |
| Planned Dates: End Date | 2008-12-31T00:00:00+00:00 |
| Planned Dates: Start Date | 2006-12-01T00:00:00+00:00 |
| Amount Awarded | 140734 |
| Financial Year | 2005/06 |
| Lead Applicant | Dr Seiffuddin Maloo |
| Grant Programme: Title | Public Engagement in Science Projects |
| Applicant Surname | Maloo |
| Approval Committee | Public Engagement Strategy Committee |
| Recipient Org: Country | Kenya |
| Recipient Org: City | Nairobi |
| Has the grant transferred? | No |
| Research conducted at multiple locations? | Yes |
| Total amount including partnership funding | 140734 |